Impact of repurposed drugs on the symptomatic COVID-19 patients

An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus capable of causing coronavirus disease 2019 (COVID-19), was declared as a global public health emergency on January 30, 2020, by the World Health Organization. In this devastating situation, precautionar...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/16422

Acceso en línea:

https://doi.org/10.1016/j.jiph.2020.11.009
http://hdl.handle.net/20.500.12010/16422

Palabra clave:

SARS-CoV-2
COVID-19
Diagnosis
Precautionary measures
Chloroquine
Hydroxychloroquine
Remdesivir
Favipiravir
Lopinavir
Ritonavir
Umifenovir
Drug toxicities
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)